Charles R. Kummeth - 06 Aug 2021 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Role
Chief Executive Officer, Director
Signature
/s/ Brenda S. Furlow as Attorney-in-Fact for Charles R. Kummeth pursuant to Power of Attorney previously filed.
Issuer symbol
TECH
Transactions as of
06 Aug 2021
Net transactions value
-$6,010,704
Form type
4
Filing time
10 Aug 2021, 18:22:31 UTC
Previous filing
21 Jun 2021
Next filing
13 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TECH Common Stock Award $0 +5,344 +3.5% $0.000000 159,750 06 Aug 2021 Direct F1
transaction TECH Common Stock Options Exercise $0 +16,918 +11% $0.000000 176,668 06 Aug 2021 Direct F1
transaction TECH Common Stock Tax liability $6,010,704 -12,475 -7.1% $481.82* 164,193 06 Aug 2021 Direct F1
holding TECH Common Stock 100 06 Aug 2021 By Step-Son
holding TECH Common Stock 100 06 Aug 2021 By Step-Daughter

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TECH Restricted Stock Units Options Exercise $0 -16,918 -100% $0.000000* 0 06 Aug 2021 Common Stock 16,918 Direct F3, F4
transaction TECH Restricted Stock Units Award $0 +8,016 $0.000000 8,016 06 Aug 2021 Common Stock 8,016 Direct F3, F12
transaction TECH Stock Options (Right to Buy) Award $0 +31,315 $0.000000 31,315 06 Aug 2021 Common Stock 31,315 $481.82 Direct F12
transaction TECH Stock Options (Right to Buy) Award $0 +20,876 $0.000000 20,876 06 Aug 2021 Common Stock 20,876 $481.82 Direct F13
holding TECH Stock Options (Right to Buy) 95,346 06 Aug 2021 Common Stock 95,346 $108.49 Direct F2
holding TECH Stock Options (Right to Buy) 79,517 06 Aug 2021 Common Stock 79,517 $108.49 Direct F2
holding TECH Stock Options (Right to Buy) 154,169 06 Aug 2021 Common Stock 154,169 $106.59 Direct F2
holding TECH Stock Options (Right to Buy) 102,779 06 Aug 2021 Common Stock 102,779 $106.59 Direct F2
holding TECH Stock Options (Right to Buy) 117,342 06 Aug 2021 Common Stock 117,342 $125.05 Direct F2
holding TECH Stock Options (Right to Buy) 78,228 06 Aug 2021 Common Stock 78,228 $125.05 Direct F2
holding TECH Stock Options (Right to Buy) 90,334 06 Aug 2021 Common Stock 90,334 $177.32 Direct F4
holding TECH Stock Options (Right to Buy) 60,222 06 Aug 2021 Common Stock 60,222 $177.32 Direct F5
holding TECH Restricted Stock Units 16,937 06 Aug 2021 Common Stock 16,937 Direct F3, F6
holding TECH Stock Options (Right to Buy) 85,725 06 Aug 2021 Common Stock 85,725 $190.41 Direct F6
holding TECH Stock Options (Right to Buy) 57,150 06 Aug 2021 Common Stock 57,150 $190.41 Direct F7
holding TECH Restricted Stock Units 12,879 06 Aug 2021 Common Stock 12,879 Direct F3, F8
holding TECH Stock Options (Right to Buy) 57,442 06 Aug 2021 Common Stock 57,442 $267.87 Direct F8
holding TECH Stock Options (Right to Buy) 38,295 06 Aug 2021 Common Stock 38,295 $267.87 Direct F9
holding TECH Stock Options (Right to Buy) 16,650 06 Aug 2021 Common Stock 16,650 $267.87 Direct F10
holding TECH Stock Options (Right to Buy) 16,650 06 Aug 2021 Common Stock 16,650 $267.87 Direct F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes (i) 3,763 shares of restricted stock for which the risk of forfeiture will lapse on August 7, 2022; (ii) 5,724 shares of restricted stock for which the risk of forfeiture will lapse as to 2,862 shares on each of August 5, 2022 and August 5, 2023; and (iii) 5,344 shares of restricted stock for which the risk of forfeiture will lapse as to 1,782 shares on August 6, 2022 and as to 1,781 shares on each of August 6, 2023 and August 6, 2024.
F2 Fully exercisable.
F3 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F4 Vested in full on 8/8/2021 upon the certification of achievement of performance goals.
F5 Options to purchase 15,056 shares vest on each of 8/8/2019 and 8/8/2020 and options to purchase 15,055 shares vest on each of 8/8/2021 and 8/8/2022.
F6 Vests in full or in part on 8/7/2022 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F7 Options to purchase 14,288 shares vest on each of 8/7/2020 and 8/7/2021 and options to purchase 14,287 shares vest on each of 8/7/2022 and 8/7/2023.
F8 Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F9 Options to purchase 9,573 shares vest on 8/5/21 and options to purchase 9,574 shares vest on each of 8/5/22, 8/5/23 and 8/5/24.
F10 Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021.
F11 Options to purchase 5,550 shares vest on each of 8/5/21, 8/5/22 and 8/5/23.
F12 Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F13 Options to purchase 5,219 shares vest on each of 8/6/2022, 8/6/2023, 8/6/2024 and 8/6/2025.